A significant shift in our drug policy has taken place, as the regulators announce the legalization of psilocybin mushrooms for therapeutic applications. Until now, these substances were strictly restricted, but a mounting body of research suggests they could offer benefits for mental health illnesses like anxiety. The new policy represents a key s